Want to see HSIC full AI Analyst Report?
Net Sales by Segment
Details revenue contribution from the company’s principal business segments, revealing which areas fuel growth or lag, how diversified the revenue base is, and whether the business mix is shifting toward higher- or lower-margin activities.Henry Schein’s 2024 resegmentation replaces historic Dental/Medical line items with 'Global Distribution & Value‑Added Services', 'Global Speciality Products' and 'Global Technology', reflecting a deliberate shift toward recurring, higher‑margin services. Management’s Q1 commentary confirms this: cloud/software and value‑added services are accelerating and driving non‑GAAP margin and adjusted EBITDA expansion, supporting buybacks and a multi‑year cost program, while specialty product growth hides implant‑mix margin pressure and medical diagnostic seasonality; freight/oil and restructuring are near‑term execution risks against the longer‑term margin thesis.
Date | Medical | Global Distribution & Value Added Services | Global Speciality Products | Global Technology | Dental | Technology & Value Added Services | Corporate TSA Revenues |
|---|---|---|---|---|---|---|---|
Jun 30, 2026 | $0.00 | $2.90B | $372.00M | $181.00M | $0.00 | $0.00 | $0.00 |
Mar 31, 2026 | $0.00 | $2.84B | $359.00M | $174.00M | $0.00 | $0.00 | $0.00 |
Dec 31, 2025 | $0.00 | $2.89B | $378.00M | $173.00M | $0.00 | $0.00 | $0.00 |
Sep 30, 2025 | $0.00 | $2.83B | $331.00M | $173.00M | $0.00 | $0.00 | $0.00 |
Jun 30, 2025 | $0.00 | $2.73B | $346.00M | $167.00M | $0.00 | $0.00 | $0.00 |
Mar 31, 2025 | $0.00 | $2.67B | $334.00M | $162.00M | $0.00 | $0.00 | $0.00 |
Dec 31, 2024 | $0.00 | $2.70B | $334.00M | $160.00M | $0.00 | $0.00 | $0.00 |
Sep 30, 2024 | $0.00 | $2.71B | $311.00M | $157.00M | $0.00 | $0.00 | $0.00 |
Jun 30, 2024 | $0.00 | $2.64B | $339.00M | $156.00M | $0.00 | $0.00 | $0.00 |
Mar 31, 2024 | $0.00 | $2.69B | $330.00M | $157.00M | $0.00 | $0.00 | $0.00 |